NCT05840718View on ClinicalTrials.gov

Supplemental Thiamine in Septic Shock: A Before-after Study

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2023

Conditions
Septic Shock
Interventions
DRUG

Thiamin

Patients in thiamine group received two daily dosis of 200 mg of thiamin diluted in 50 ml of 5% dextrose during 7 days

Trial Locations (2)

65060645

Hospital São Domingos, São Luís

65060-000

Hospital Sao Domingos, São Luís

All Listed Sponsors
lead

Hospital Sao Domingos

OTHER

NCT05840718 - Supplemental Thiamine in Septic Shock: A Before-after Study | Biotech Hunter | Biotech Hunter